Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
multivalent gonorrhoea vaccine
- Development stage
- Unknown
- Lead developer
- LimmaTech Biologics
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The multivalent gonorrhoea vaccine (also known as LBT-GON) is a bioconjugate vaccine candidate developed by LimmaTech Biologics for the prevention of infections caused by *Neisseria gonorrhoeae*. The vaccine is engineered using LimmaTech's proprietary bioconjugation technology, which enzymatically links bacterial polysaccharides to carrier proteins to enhance the immune response. By targeting multiple antigens, the vaccine aims to provide broad protection against diverse strains of the pathogen, including multidrug-resistant gonorrhea. As of 2024, the vaccine is undergoing Phase 1 clinical evaluation to assess its safety, tolerability, and immunogenicity in healthy adults.
- Other names
- LBT-GON
02
Targets
TLR2 (Toll-like Receptor 2)LOS (Conserved lipooligosaccharide epitopes of Neisseria gonorrhoeae)
Beyond the preview
Go deeper on multivalent gonorrhoea vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on multivalent gonorrhoea vaccine.